[HTML][HTML] Bioinformatic Identification of Signaling Pathways and Hub Genes in Vascular Dementia
Y Wu, J Cai, B Pang, L Cao, Q He, Q He… - Actas Españolas de …, 2024 - ncbi.nlm.nih.gov
Background Vascular dementia (VaD) is a prevalent neurodegenerative disease
characterized by cognitive impairment due to cerebrovascular factors, affecting a significant …
characterized by cognitive impairment due to cerebrovascular factors, affecting a significant …
An In vivo Investigation of Ascorbic Acid Tethered Polymeric Nanoparticles for Effectual Brain Transport of Rivastigmine
KR Gajbhiye, V Soni - Current Drug Delivery, 2023 - ingentaconnect.com
Introduction: The goal of this study was to see if ascorbic acid grafted polylactic glycolic acid-
b-polyethylene glycol nanoparticles (PLGA-b-PEG NPs) might boost the carrying or transport …
b-polyethylene glycol nanoparticles (PLGA-b-PEG NPs) might boost the carrying or transport …
Nanomedicine: A New Frontier in Drug Delivery Systems
AKMS Kadir, PK Prabhakar, MU Shemanto… - … with Cutting-Edge …, 2024 - igi-global.com
The chapter explores the transformative potential of nanomedicine in revolutionizing drug
delivery. Nanomedicine, combining nanotechnology and medicine, offers innovative …
delivery. Nanomedicine, combining nanotechnology and medicine, offers innovative …
Diseño y evaluación de un hidrogel cargado con puntos cuánticos de carbono conjugados con un inhibidor de beta secretasa, en un modelo de Alzheimer
CG Uribe - 2022 - cicese.repositorioinstitucional.mx
La enfermedad de Alzheimer (EA) es un proceso neurodegenerativo, crónico, progresivo e
irreversible en adultos mayores de 65 años. La EA se desencadena por la acción de β …
irreversible en adultos mayores de 65 años. La EA se desencadena por la acción de β …
Emerging Nanomaterial-Based Medications: Key Challenges and Opportunities
J Reis, T Oliveira, R Payan-Carreira - Bio-manufactured Nanomaterials …, 2021 - Springer
Nanomaterial-based medications have a wealth of potential innovative clinical applications,
representing possible solutions for long-standing clinical challenges whether considering …
representing possible solutions for long-standing clinical challenges whether considering …
[PDF][PDF] Lipid nanostructures for targeting brain cancer 2
Lipid nanostructures for targeting brain cancer Page 1 Journal Pre-proof Lipid nanostructures
for targeting brain cancer Hamdi Nsairat, Dima Khater, Fadwa Odeh, Fedaa Al-Adaileh, Suma …
for targeting brain cancer Hamdi Nsairat, Dima Khater, Fadwa Odeh, Fedaa Al-Adaileh, Suma …
Últimos avances en la búsqueda de sustancias contra el Alzheimer
LC Marchant Solis - 2021 - dspace.utalca.cl
La Enfermedad de Alzheimer (EA) representa la causa más común de demencia en
ancianos, siendo responsable de entre un 60 y un 80 por ciento de los casos de demencia …
ancianos, siendo responsable de entre un 60 y un 80 por ciento de los casos de demencia …